You are not alone with the product.
Setup is supported. Onboarding is staffed by humans. There is a person on our team you can reach when something is unclear, and that person is an RN with a dementia background.
Trust / How we bring this to market
Slowly. Carefully. With evidence.
Voice continuity in aiding caregivers is a new technology. We refuse to ship it the way most consumer software gets shipped. The population is too vulnerable. The stakes are too high.
What this looks like for you
Every caregiver gets more support, not less.
Every caregiver who comes through Proxi today gets more support, more attention, and more access to our clinical team than will be possible at scale. Not because you are a test subject. Because the right way to do this is to start small and stay close.
Your conversations are reviewed during the early period.
Not for surveillance. For safety and quality. Our clinical team reviews calls during the early period of your service to make sure your Proxi is doing what you authorized, the way you authorized it. Once the system is calibrated to your situation, the review tapers. You can ask us to continue, pause, or stop the review at any time.
Over 100 years of combined dementia care experience is on staff.
Our clinical team has been in this work for decades. They have built memory care units from the ground up. They have designed dementia behavior intervention programs that won state awards. They have trained the staff who train other staff. Their job here is to notice what nobody else would notice, in time.
Voluntary research
Voluntary participation, separate consent.
Some families opt into voluntary biometric monitoring beyond the normal service. Voluntary, opt-in, separate consent, no effect on your service if you decline.
What we are studying, with their help:
A research question we are exploring with families who opt into biometric monitoring. Heart rate, oxygen, activity. Whether voice patterns and physiology tell the same story.
A research question: whether a voice service could one day spot the early signal of a urinary tract infection. UTIs in dementia patients often show up as sudden confusion. They are common, treatable, and dangerous when missed. Proxi does not detect UTIs today.
A research question: whether a voice service could one day spot a sudden change in cognitive baseline that warrants a clinical visit. Not diagnose. Notice. Proxi does not do this today.
Whether caregivers who use Proxi sleep more, work more, stay more themselves. Whether the relationship with their loved one improves. Whether the burden numbers come down.
These are open clinical research questions today. The answers will come from the families who help us answer them. When we have answers, we will publish them.
Scope and limits
Proxi is not medical care.
Proxi is not a medical device, not a diagnostic tool, and not a substitute for clinical care. We do not interpret what a conversation pattern means medically. That is your clinician’s job.
If that ever changes
If we ever pursue medical-grade capabilities, we will do it through the right regulatory pathway, with proper studies and clearance. We will not market disease detection or diagnostic claims before then.
The boundary
What Proxi is not, and stays not.
Proxi is voice continuity for caregivers, with a safety architecture built for the population it serves, brought to market carefully so it actually helps and does not harm. The five lines that mark the edge of that, and what the safety team watches for inside it, are set out in one place.
Why we build this way
We could ship faster by skipping the white-glove onboarding, by treating early caregivers like beta testers, by claiming medical detection capabilities we are still researching, by promising what we have not yet proven. Other voice products have done all of those things. They are setting up the lawsuit and the regulator that destroys them.
We are building this for caregivers who already lost too much. Anything we ship has to actually work, and has to not harm. The slower path is the only one that gets there.